http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-125272-C2
Outgoing Links
Predicate | Object |
---|---|
filingDate | 2020-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | UA-125272-C2 |
titleOfInvention | PRODUCT IN THE FORM OF GEL COMPOSITION "BENZIDAFLASIVERDINE" WITH PROLONGED ACTION FOR THE TREATMENT OF PERIODONTIC TISSUE DISEASES |
abstract | The invention relates to medicine, namely dentistry, and can be used for the conservative treatment of inflammatory and dystrophic-inflammatory diseases of periodontal tissues. The proposed agent contains as active ingredient benzydamine hydrochloride in the form of ground to a powdery tablet T-sept and additionally contains as active ingredient proteflazide in the composition of the gel base containing sodium alginate, nipagin and water for injection, in the appropriate ratio. |
priorityDate | 2020-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 13.